Jones David S, Djokic Jasmina, McCoy Colin P, Gorman Sean P
Medical Devices Unit, School of Pharmacy, Medical Biology Centre, The Queen's University of Belfast, Northern Ireland, UK.
Biomaterials. 2002 Dec;23(23):4449-58. doi: 10.1016/s0142-9612(02)00158-8.
This study describes the physicochemical properties and in vitro resistance to encrustation of solvent cast films composed of either poly(epsilon-caprolactone) (PCL), prepared using different ratios of high (50,000) to low (4000) (molecular weight) m.wt., or blends of PCL and the polymeric antimicrobial complex, poly(vinylpyrrolidone)-iodine (PVP-I). The incorporation of PVP-I offered antimicrobial activity to the biomaterials. Films were characterised in terms of mechanical (tensile analysis, dynamic mechanical thermal analysis) and surface properties (dynamic contact angle analysis, scanning electron microscopy), whereas degradation (at 37 degrees C in PBS at pH 7.4) was determined gravimetrically. The resistance of the films to encrustation was evaluated using an in vitro encrustation model. Reductions in the ratio of high:low-m.wt. PCL significantly reduced the ultimate tensile strength, % elongation at break and the advancing contact angle of the films. These effects were attributed to alterations in the amorphous content and the more hydrophilic nature of the films. Conversely, there were no alterations in Young's modulus, the viscoelastic properties and glass-transition temperature. Incorporation of PVP-I did not affect the mechanical or rheological properties of the films, indicative of a limited interaction between the two polymers in the solid state. Manipulation of the high:low m.wt. ratio of PCL significantly altered the degradation of the films, most notably following longer immersion periods, and resistance to encrustation. Accordingly, maximum degradation and resistance to encrustation was observed with the biomaterial composed of 40:60 high:low m.wt. ratios of PCL; however, the mechanical properties of this system were considered inappropriate for clinical application. Films composed of either 50:50 or 60:40 ratio of high:low m.wt. PCL offered an appropriate compromise between physicochemical properties and resistance to encrustation. This study has highlighted the important usefulness of degradable polymer systems as ureteral biomaterials.
本研究描述了由聚(ε-己内酯)(PCL)制成的溶剂浇铸膜的物理化学性质和体外抗结垢性,PCL采用不同比例的高(50,000)到低(4000)分子量制备,或PCL与聚合物抗菌复合物聚(乙烯基吡咯烷酮)-碘(PVP-I)的共混物。PVP-I的加入赋予了生物材料抗菌活性。通过机械性能(拉伸分析、动态机械热分析)和表面性能(动态接触角分析、扫描电子显微镜)对薄膜进行了表征,而降解情况(在37℃、pH 7.4的PBS中)通过重量法测定。使用体外结垢模型评估薄膜的抗结垢性。高低分子量PCL比例的降低显著降低了薄膜的极限拉伸强度、断裂伸长率和前进接触角。这些影响归因于薄膜无定形含量的变化和更亲水的性质。相反,杨氏模量、粘弹性和玻璃化转变温度没有变化。PVP-I的加入不影响薄膜的机械或流变性能,这表明两种聚合物在固态下的相互作用有限。PCL高低分子量比例的改变显著改变了薄膜的降解情况,在较长浸泡时间后最为明显,以及抗结垢性。因此,由40:60高低分子量比例的PCL组成的生物材料观察到最大降解和抗结垢性;然而,该系统的机械性能被认为不适合临床应用。由50:50或60:40高低分子量比例的PCL组成的薄膜在物理化学性质和抗结垢性之间提供了适当的折衷。本研究突出了可降解聚合物系统作为输尿管生物材料的重要实用性。